跳至主要内容
临床试验/NCT05250817
NCT05250817已完成不适用

Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer

Bristol-Myers Squibb1 个研究点 分布在 1 个国家目标入组 501 人开始时间: 2021年12月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
501
试验地点
1
主要终点
Set of relative preference weights for all attribute levels included in the Discrete Choice Experiment (DCE)

研究概览

简要总结

The purpose of this observational study is to determine participants' preferences for outcomes associated with first-line treatment of advanced/metastatic Non-Small Cell Lung Cancer (NSCLC) using a discrete-choice experiment (DCE).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The following is the inclusion criteria for pretest interviews and final online survey.
  • Participants:
  • Must be 18 years of age or older
  • Must be a US resident.
  • Lung cancer participants with a physician diagnosis of NSCLC. Global Perspectives will be involved to suggest alternative strategies to a physician-confirmed diagnosis to ensure that actual cancer participants are recruited.

排除标准

  • Not applicable
  • Other protocol-defined inclusion/exclusion criteria apply

结局指标

主要结局

Set of relative preference weights for all attribute levels included in the Discrete Choice Experiment (DCE)

时间窗: At Baseline

Respondents' baseline understanding of attribute descriptions

时间窗: At Baseline

次要结局

未报告次要终点

研究者

发起方
Bristol-Myers Squibb
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验